B|Braun Pump System for Tracheal Delivery of Nebulized Medications

B|Braun received U.S. Federal Drug and Administration (FDA) Emergency Use Authorization (EUA) for some of its pump systems for the tracheal delivery of continuous nebulized medications into a nebulizer to treat confirmed and suspected patients, regardless of age, with severe acute respiratory syndrome coronavirus (SARS-CoV-2) commonly known as the coronavirus (COVID-19). This was enacted to decrease healthcare providers (HCP) exposure to confirmed or suspected patients with COVID-19. Learn more by accessing this document.

Please Register or Login

You must be logged in to access exclusive content within our clinical resources.

Register Log-in